Table 3.
No | Study (Year) | MPAP (mmHg) | Systolic RV Pressure (mmHg) | TAPSE | Interventricular Septal Curvature | End-diastolic RV/LV Diameter Ratio | ||||||||||
Pre | Post | Follow Up | Pre | Post | Follow Up | Pre | Post | Follow Up | Pre | Post | Follow Up | Pre | Post | Follow Up | ||
1 | Aggarwal et al (2018) | N/A | N/A | N/A | 81(71-98) | 81 (77-99) | N/A | 11.5 (10.4-12.4) | 12.6 (11.7-13.8) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
2 | Baruteau et al (2014) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Inverted | Flattened | N/A | N/A | N/A | N/A |
3 | Bobhate et al (2021) | 79.5 (66.8-89.0) | N/A | 75 (44-89) | N/A | N/A | N/A | -3.9 ± 1.3 | N/A | -1.3 ± 1.5 | N/A | N/A | N/A | N/A | N/A | N/A |
4 | Boudjemline et al (2017) | N/A | N/A | N/A | N/A | N/A | N/A | -2.1 (-2.8 - 1.1) | N/A | 0.3 (-1.5 - 2.6) | N/A | N/A | N/A | N/A | N/A | N/A |
5 | Grady et al (2016) | 53 (51-87) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
6 | Gorbachevsky et al (2017) | 86.6 ± 11.9 | N/A | N/A | 109.7 ± 9.4 | 98.7 ± 9.3 | 99.5 ± 8.6 | N/A | N/A | N/A | N/A | N/A | N/A | 1.36 ± 0.14 | 0.99 ± 0.22 | 0.90 ± 0.30 |
7 | Kirkpatrick et al (2018) | N/A | N/A | N/A | 116 ± 21.7 | 130* | N/A | N/A | N/A | N/A | Flattened | N/A | N/A | N/A | N/A | N/A |
LV, left ventricle; MPAP, mean pulmonary arterial pressure; N/A, not available; RV, right ventricle; TAPSE, tricuspid annular plane systolic excursion.
*Only included patients with available data